Table 4 Thirty-day PE related mortality, major bleeding and VTE recurrences of different prognosis tools.
30-day PE-related mortality | 30-day major bleeding | 30-day VTE recurrences | ||
|---|---|---|---|---|
(n = 31) | (n = 45) | (n = 63) | ||
N (%) | N (%) | N (%) | ||
PESI22 | Low risk | 14 (45.2%) | 29 (64.4%) | 40 (63.5%) |
High risk | 17 (54.8%) | 16 (35.6%) | 23 (36.5%) | |
sPESI23 | Low risk | 5 (16.1%) | 16 (35.6%) | 22 (34.9%) |
High risk | 26 (83.9%) | 29 (64.4%) | 41 (65.1%) | |
Shock Index26 | Low risk | 12 (38.7%) | 26 (57.8%) | 39 (62.9%) |
High risk | 19 (61.3%) | 19 (42.2%) | 23 (37.1%) | |
GPS21 | Low risk | 18 (58.1%) | 35 (77.8%) | 45 (71.4%) |
High risk | 13 (41.9%) | 10 (22.2%) | 18 (28.6%) | |
Prognostic Algorithm24 | Low risk | 3 (9.7%) | 15 (33.3%) | 21 (33.3%) |
High risk | 28 (90.3%) | 30 (66.7%) | 42 (66.7%) | |
PREP25 | Low risk | 26 (83.9%) | 42 (93.3%) | 59 (93.7%) |
High risk | 5 (16.1%) | 3 (6.7%) | 4 (6.4%) | |
RIETE score27 | Low risk | 4 (12.9%) | 12 (26.7%) | 20 (31.8%) |
High risk | 27 (87.1%) | 33 (73.3%) | 43 (68.3%) | |